<DOC>
	<DOCNO>NCT00153036</DOCNO>
	<brief_summary>To collect additional confirmatory data alteplase ( rt-PA ) European set demonstrate treatment patient 3 4.30 hour onset symptom acute ischemic stroke rt-PA compare placebo-treated patient result improved clinical outcome without increase fatality rate .</brief_summary>
	<brief_title>Rt-PA Treatment Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Female male inpatient Age : 18 80 year . Clinical diagnosis ischemic stroke cause measurable neurological deficit define impairment language , motor function , cognition and/or gaze , vision neglect . Ischemic stroke defined event characterize sudden onset acute focal neurologic deficit presume due cerebral ischemia CT scan excludes hemorrhage . Onset symptoms 3 4 hour prior initiation administration study drug . Stroke symptoms present least 30 minute significantly improve treatment . Symptoms must distinguishable episode generalize ischemia ( i.e . syncope ) , seizure , migraine disorder . Patient willing participate voluntarily sign write patient inform consent . Informed consent obtain patient subject 's legally authorize representative relative , defer applicable , accord regulatory legal requirement participate country . Patients unable sign able understand mean participation study may give oral witness informed consent . These patient make clear undoubtfully willing participate voluntarily must able understand explanation content information sheet . Willingness ability comply protocol . Evidence intracranial hemorrhage ( ICH ) CTscan . Symptoms ischaemic attack begin 4 hour 30 minute prior infusion start time symptom onset unknown . Minor neurological deficit symptom rapidly improve start infusion . Severe stroke assess clinically ( e.g . NIHSS &gt; 25 ) and/or appropriate imaging technique . Epileptic seizure onset stroke Symptoms suggestive subarachnoid haemorrhage , even CTscan normal . Administration heparin within previous 48 hour thromboplastin time exceed upper limit normal laboratory History prior stroke concomitant diabetes . * Prior stroke within last 3 month Platelet 100,000/mm3 . * Systolic blood pressure &gt; 185 mmHg diastolic blood pressure &gt; 110 mmHg , aggressive management ( IV medication ) necessary reduce BP limit . Blood glucose &lt; 50 &gt; 400 mg/dl ( &lt; 2.77 &gt; 22.15 mmol / l ) . * Known haemorraghic diathesis Patients receive oral anticoagulant . * Manifest recent severe dangerous bleed Known history suspect intracranial haemorrhage Suspected subarachnoid haemorrhage condition subarachnoid haemorrhage aneurysm History central nervous system damage ( i.e . neoplasm , aneurysm , intracranial spinal surgery ) Haemorrhagic retinopathy , e.g . diabetes ( vision disturbance may indicate haemorrhagic retinopathy ) Recent ( less 10 day ) traumatic external heart massage , obstetrical delivery , recent puncture noncompressible bloodvessel ( e.g . subclavian jugular vein puncture . bacterial endocarditis , pericarditis . * Acute pancreatitis Documented ulcerative gastrointestinal disease last 3 month , oesophageal varix , arterial aneurysm , arterial/venous malformation Neoplasm increase bleeding risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>